Implantable cardioverter-defibrillator endocarditis secondary to Candida albicans

Am J Med Sci. 2001 Sep;322(3):160-2. doi: 10.1097/00000441-200109000-00010.

Abstract

The implantable cardioverter-defibrillator (ICD) represents an important advance in the treatment of ventricular arrhythmias, but infection has remained a serious complication of device implantation. Fungal infections associated with these devices are uncommon, with only 4 cases previously reported. We describe a case of ICD-associated endocarditis caused by Candida albicans that was successfully treated with complete device explantation and prolonged antifungal therapy, and we review the features of ICD-related fungal infections.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Candidiasis / drug therapy
  • Candidiasis / etiology*
  • Defibrillators, Implantable / adverse effects*
  • Endocarditis / drug therapy
  • Endocarditis / etiology*
  • Humans
  • Male
  • Middle Aged
  • Prosthesis-Related Infections / drug therapy
  • Prosthesis-Related Infections / etiology*
  • Tachycardia, Ventricular / therapy

Substances

  • Antifungal Agents
  • Amphotericin B